Skip to main content
. 2022 Oct 20;9(5):429–435. doi: 10.14744/nci.2022.09634

Table 4.

Clinical characteristics and laboratory data of patients with COVID-19 positive T1DM presenting with DKA

  COVID-19 PCR + (n=4) COVID-19 Anti-body + (n=2)
  Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Age (months) 38.0 174.0 107.0 62.0 136.0 167.0
Sex Female Female Male Female Male Male
Diagnose New diagnose New diagnose New diagnose New diagnose New diagnose New diagnose
Subcutaneous insulin time 24.0 20.0 24.0 22.0 336.0 96.0
Glucose (mg/dl) 496.0 390.0 657.0 356.0 946.0 321.0
HgbA1c (%) 10.70 13.00 11.20 12.90 13.30 15.00
pH 6.99 6.90 6.89 7.09 6.90 7.01
HCO3 (mmol/l) 6.90 5.90 5.80 4.80 5.20 5.40
Lactate (mmol/l) 2.0 0.5 1.90 0.95 1.70 1.0
Urinary ke-tone + + +++ +++ +++ +
Procalcitonin (µg/l) 1.64 0.59 0.29 0.23 0.03
CRP (mg/l) 1.02 24.2 0.40 14.15 0.60 0.60

DKA: Diabetic ketoacidosis; T1DM: Type 1 diabetes mellitus; HCO3: Actual bicarbonate value in blood gas analysis; CRP: C-reactıve proteın value.